Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Jean‐Nicolas Vauthey et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255
Defining Venous Involvement in Borderline Resectable Pancreatic CancerYun Shin Chun, John P. Hoffman, Barton N. Milestone et al.|Annals of Surgical Oncology|2010Cited by 132